Clinical Trials Directory

Trials / Unknown

UnknownNCT05449873

No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet Electrodes

No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Locoregional Treatment Using Combined Energy Delivery Mode and Triple Cooled-Wet Electrodes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
73 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To evaluate local tumor progression rate at 12 months after no-touch percutaneous radiofrequency ablation using combined energy delivery mode and triple cooled electrodes

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency ablation using combined bipolar and monopolar energy deliver with Triple Cooled-Wet electrodesRadiofrequency ablation will be performed by using triple cooled-wet electrodes. Two or three electrodes will be places around the tumor under ultrasonography (US)-computed tomography (CT)/magnetic resonance (MR) fusion tool guidance. The electrodes will be cooled with saline, and radiofrequency (RF, bipolar mode and switching monopolar mode) will be applied to two of three electrodes at the same time for about 6 to 30 minutes depending on the tumor size. The temperature will be maintained at 90-100 °C.

Timeline

Start date
2021-10-18
Primary completion
2023-07-30
Completion
2023-07-30
First posted
2022-07-08
Last updated
2022-10-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05449873. Inclusion in this directory is not an endorsement.

No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet Electrodes (NCT05449873) · Clinical Trials Directory